Telix Pharmaceuticals

IN · United States · Reporting entity ID 100001171890

Total reported 2019–2025

$3.35M

#847 of 2,960 reporting companies — 0% of all reported industry payments

$2.49M in general payments across 10,142 records, plus $863K in research funding across 129 records.

How it breaks down

General payments $2,490,334

Research funding $862,612

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.